Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we have studied the possible mechanism of action of ivermectin using in silico approaches. Materials & methods: Interaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Abhigyan, Das, Nabarun C, Patra, Ritwik, Bhattacharya, Manojit, Ghosh, Pratik, Patra, Bidhan C, Mukherjee, Suprabhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996102/
http://dx.doi.org/10.2217/fvl-2020-0342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996102/
http://dx.doi.org/10.2217/fvl-2020-0342

Ejemplares similares